Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.8441
Handel nachbörslich:
.77
0.77
+
Schlusskurs vom Vortag:
$0.8441
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$10.56M
Einnahmen:
$895.50K
Nettoeinkommen (Verlust:
$-26.30M
KGV:
0.00
EPS:
-65.5728
Netto-Cashflow:
$-23.84M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$2.17
Mainz Biomed N V Stock (MYNZ) Company Profile
Firmenname
Mainz Biomed N V
Sektor
Branche
Telefon
-
Adresse
-
Compare MYNZ vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
0.00 | 10.56M | 895.50K | -26.30M | -23.84M | -65.57 |
TMO
Thermo Fisher Scientific Inc
|
464.61 | 172.66B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.17 | 125.40B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.09 | 44.34B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
127.06 | 35.89B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
355.44 | 34.90B | 3.77B | 449.25M | 240.68M | 7.8556 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Maxim Group | Buy |
| 2024-11-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
Mainz Biomed N V Ord Shs (QUCY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mainz Biomed NV (MYNZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mainz Biomed NV (MYNZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mainz Biomed NV (MYNZ) Institutional Confidence - TradingKey
Mainz Biomed NV (MYNZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Institutional Confidence - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mainz Biomed NV (MYNZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mainz Biomed NV (MYNZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mainz Biomed NV (MYNZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mainz Biomed Q4 2023 Earnings: EPS Beats Estimates Despite No Reported RevenueProfit Inflection Point - newsline.com
Mainz Biomed Q4 2023 Earnings: EPS Beats Expectations Amid Operational ChallengesProfit Guidance Range - newsline.com
[8-K] Quantum Cyber N.V. Reports Material Event - Stock Titan
Mainz Biomed (QUCY) Q4 2023 Earnings: Narrowed Loss Beats Estimates, Stock RalliesNegative Surprise Momentum - newsline.com
Mainz Biomed Q4 2023 Earnings: EPS Beat Amid Revenue Uncertainty, Stock Declines 14%Earnings Surprise Report - newsline.com
Quantum Cyber (NASDAQ: MYNZ) restores Nasdaq minimum bid rule compliance - Stock Titan
Director Ben-Tzvi Avraham granted 137,141 Quantum Cyber (MYNZ) shares - Stock Titan
Quantum Cyber (Nasdaq: QUCY) raises $15M and wipes out all debt - Stock Titan
Mainz Biomed (QUCY) Slides 6.5% as Stock Tests Key Support ZoneBreakaway Gap - The Legal Advocate
Mainz Biomed N.V. Ordinary Shares Q4 2023 Earnings: EPS Beat Estimate Despite Absence of Revenue, Stock DeclinesEnergy Earnings Report - Newser
From Cancer Tests to Combat Drones: Mainz Biomed's Radical Reinvention Nears a Key Vote - AD HOC NEWS
Mainz Biomed’s Big Pivot: New Name, New Risks, Same Volatility - Finimize
Quantum Cyber's Patent Salvo Drives Stock Rally Amid Insider Share Awards and Cash Concerns - AD HOC NEWS
Guido Baechler files Form 144 to sell 200,000 MYNZ shares (MYNZ) - Stock Titan
Quantum Cyber N.V. and Other Players Eye Potential CHIPS Act Funding From Trump Administration - The Globe and Mail
Quantum Cyber (QUCY) director files Form 3 reporting zero ordinary shares - Stock Titan
Quantum Cyber (NASDAQ: MYNZ) director awarded 137,141 ordinary shares in Form 4 filing - Stock Titan
Quantum Cyber forms US defense subsidiary for drone programs - MSN
QUCY Stock Price, Quote & Chart | QUANTUM CYBER NV (NASDAQ:QUCY) - ChartMill
[144] Quantum Cyber N.V. SEC Filing - Stock Titan
Quantum Cyber (MYNZ) inks exclusive IP license with $5M cash and shares - Stock Titan
Mainz Biomed N.v. Live Share Prices and Trades. QUCY.US Live Streaming Share Prices. - London South East
[10-Q] Quantum Cyber N.V. Quarterly Earnings Report - Stock Titan
Quantum Cyber site spotlights drones as Trump administration seeks $55B - Stock Titan
Quantum Cyber N.V. (QUCY-Q) Stock Price and News - The Globe and Mail
3 Penny Stocks to Watch Now, 5/14/26 - TipRanks
Quantum Cyber Stock Surges As Drone Deal And Ex-VA Chief Put Defense Pivot In Focus - TechStock²
Quantum Cyber appoints former VA acting secretary to board - Investing.com India
Mainz Biomed Stock Surges 315% as QUCY Hits $1.34 on Massive Volume - Meyka
Quantum Cyber N.V.Ordinary Shares (NQ: QUCY - FinancialContent
Quantum Cyber N.V. (QUCY) Stock: Drone Defense Deal Sparks 69% Rally - MEXC Exchange
Quantum Cyber N.V. (QUCY) Stock Soars 69% on BP United Drone Defense Partnership - MEXC Exchange
Cisco, Nokia, Ford, Quantum Cyber And Nebius Group: Why These 5 Stocks Are On Investors' Radars Today - Sahm
TradingKey - TradingKey
MSN Money - MSN
Quantum Cyber (MYNZ) boosts ATM share program to $100M, sets CFO consulting deal - Stock Titan
Finanzdaten der Mainz Biomed N V-Aktie (MYNZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):